tradingkey.logo


tradingkey.logo


Agilent Technologies Inc

A
113.010USD
+0.990+0.88%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
39.44BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
24.84P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Agilent Technologies Inc āļšāļĢāļīāļĐāļąāļ—

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

āļ‚āđ‰āļ­āļĄāļđāļĨ Agilent Technologies Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™A
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Agilent Technologies Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 18, 1999
āļ‹āļĩāļ­āļĩāđ‚āļ­Mcdonnell (Padraig)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™- -
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Nov 18
āļ—āļĩāđˆāļ­āļĒāļđāđˆ5301 Stevens Creek Blvd
āđ€āļĄāļ·āļ­āļ‡SANTA CLARA
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ95051
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ14083458886
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.agilent.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™A
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 18, 1999
āļ‹āļĩāļ­āļĩāđ‚āļ­Mcdonnell (Padraig)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Agilent Technologies Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.65K
+0.17%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.50K
+0.37%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.95K
+0.77%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
18.66K
-161.92%
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.18K
+0.75%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
--
Mr. Adam Stewart Elinoff
Mr. Adam Stewart Elinoff
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
11.73K
--
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.81K
+0.73%
Dr. Simon May
Dr. Simon May
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
1.66K
-731.33%
Mr. Pascal Soriot
Mr. Pascal Soriot
Independent Director
Independent Director
1.17K
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.65K
+0.17%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.50K
+0.37%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.95K
+0.77%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
18.66K
-161.92%
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.18K
+0.75%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Non-instrumentation and other
4.52B
65.07%
Instrumentation
2.43B
34.93%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
2.81B
40.39%
Asia Pacific
2.22B
31.94%
Europe
1.92B
27.68%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Non-instrumentation and other
4.52B
65.07%
Instrumentation
2.43B
34.93%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
5.20%
MFS Investment Management
4.66%
State Street Investment Management (US)
4.49%
T. Rowe Price Investment Management, Inc.
2.88%
āļ­āļ·āđˆāļ™ āđ†
70.75%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
5.20%
MFS Investment Management
4.66%
State Street Investment Management (US)
4.49%
T. Rowe Price Investment Management, Inc.
2.88%
āļ­āļ·āđˆāļ™ āđ†
70.75%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
44.88%
Investment Advisor/Hedge Fund
35.89%
Hedge Fund
3.63%
Research Firm
2.17%
Pension Fund
2.15%
Insurance Company
1.68%
Sovereign Wealth Fund
1.47%
Bank and Trust
1.31%
Family Office
0.44%
āļ­āļ·āđˆāļ™ āđ†
6.39%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
2057
261.01M
94.90%
-134.75K
2025Q3
2120
261.17M
95.32%
-153.68K
2025Q2
2118
261.09M
93.90%
+1.73M
2025Q1
2146
261.16M
94.63%
-8.63M
2024Q4
2129
260.37M
94.60%
-340.38K
2024Q3
2073
260.94M
95.43%
-3.57M
2024Q2
2043
263.64M
96.52%
-5.86M
2024Q1
2043
270.13M
95.69%
-10.33M
2023Q4
2063
269.78M
93.21%
+5.05M
2023Q3
1993
263.26M
94.34%
-4.53M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
33.91M
11.96%
+39.32K
+0.12%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.95M
5.27%
+91.77K
+0.62%
Sep 30, 2025
MFS Investment Management
11.51M
4.06%
-681.27K
-5.59%
Sep 30, 2025
State Street Investment Management (US)
12.44M
4.39%
-12.77K
-0.10%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.15M
2.87%
-13.65K
-0.17%
Sep 30, 2025
Wellington Management Company, LLP
9.38M
3.31%
+433.34K
+4.84%
Sep 30, 2025
Geode Capital Management, L.L.C.
7.40M
2.61%
+81.19K
+1.11%
Sep 30, 2025
Pictet Asset Management Ltd.
5.26M
1.85%
+485.39K
+10.17%
Sep 30, 2025
DWS Investment GmbH
4.55M
1.6%
+741.64K
+19.48%
Sep 30, 2025
State Farm Insurance Companies
4.52M
1.59%
--
--
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Honeytree US Equity ETF
5.06%
First Trust Water ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
3.87%
VanEck Morningstar Wide Moat Value ETF
3.31%
Madison Covered Call ETF
3.27%
iShares Health Innovation Active ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.87%
Argent Mid Cap ETF
2.57%
Global X Genomics & Biotechnology ETF
2.4%
Invesco Zacks Mid-Cap ETF
2.29%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Honeytree US Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.06%
First Trust Water ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.76%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.87%
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.31%
Madison Covered Call ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.27%
iShares Health Innovation Active ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.9%
VanEck Morningstar Wide Moat ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.87%
Argent Mid Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.57%
Global X Genomics & Biotechnology ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.4%
Invesco Zacks Mid-Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.29%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 1.31B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Feb 11, 2026
A.NB Interim Cash Dividend of gross USD 0.255 paid on Apr 22, 2026 going ex on Mar 31, 2026 with reinvestment option
Mar 31, 2026
Apr 22, 2026
Mar 31, 2026
Nov 19, 2025
A.NB Interim Cash Dividend of gross USD 0.255 paid on Jan 28, 2026 going ex on Jan 06, 2026 with reinvestment option
Jan 06, 2026
Jan 28, 2026
Jan 06, 2026
Sep 17, 2025
A.NB Final Cash Dividend of gross USD 0.248 paid on Oct 22, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 22, 2025
Sep 30, 2025
May 21, 2025
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jul 23, 2025 going ex on Jul 01, 2025 with reinvestment option
Jul 01, 2025
Jul 23, 2025
Jul 01, 2025
Feb 19, 2025
A.NB Interim Cash Dividend of gross USD 0.248 paid on Apr 23, 2025 going ex on Apr 01, 2025 with reinvestment option
Apr 01, 2025
Apr 23, 2025
Apr 01, 2025
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™